Tecentriq 1200 mg/20 ml vial concentrate for inf
100805.00 جنيها
معلومات الدواء
الإسم التجاري
Tecentriq 1200 mg/20 ml vial concentrate for inf -الإسم العلمي
Atezolizumab
Tecentriq
is a monoclonal antibody designed to bind with a protein called pd-l1 expressed on tumour cells and tumour-infiltrating immune cells, blocking its interactions with both pd-1 and b7.1 receptors. by inhibiting pd-l1, tecentriq may enable the activation of t cells.indicationslocally advanced or metastatic urothelial carcinoma.metastatic non-small cell lung cancer.
is a monoclonal antibody designed to bind with a protein called pd-l1 expressed on tumour cells and tumour-infiltrating immune cells, blocking its interactions with both pd-1 and b7.1 receptors. by inhibiting pd-l1, tecentriq may enable the activation of t cells.indicationslocally advanced or metastatic urothelial carcinoma.metastatic non-small cell lung cancer.
Tecentriq
is a monoclonal antibody designed to bind with a protein called pd-l1 expressed on tumour cells and tumour-infiltrating immune cells, blocking its interactions with both pd-1 and b7.1 receptors. by inhibiting pd-l1, tecentriq may enable the activation of t cells.indicationslocally advanced or metastatic urothelial carcinoma.metastatic non-small cell lung cancer.
is a monoclonal antibody designed to bind with a protein called pd-l1 expressed on tumour cells and tumour-infiltrating immune cells, blocking its interactions with both pd-1 and b7.1 receptors. by inhibiting pd-l1, tecentriq may enable the activation of t cells.indicationslocally advanced or metastatic urothelial carcinoma.metastatic non-small cell lung cancer.
تنبيه بخصوص المعلومات المتوفرة علي موقع دليل الدواء
بينما نعمل دائما علي تنقيح وتحسين البيانات المعروضة علي موقعنا إلا أننا ننصح دائما بعدم تعاطي أي دواء بدون إستشارة الطبيب المختص، ولا يتحمل الموقع أي مسئولية ناتجة عن سوء استخدام الأدوية بدون استشارة المختص، في حال وجدت أي بيانات خاطئة أو سعر دواء غير صحيح برجاء الإتصال بنا لتصحيحه.
البدائل
339 دواء
اسم الدواء
السعر